Target intelligence / Profile preview

Transmembrane protein 81 (TMEM81)

Target
TMEM81
Molecular classification
Transmembrane protein, Immunoglobulin-like domain protein, Type I transmembrane protein
01

Overview

Transmembrane protein 81 (TMEM81) is a type I transmembrane glycoprotein with a single-pass helical transmembrane domain, a large extracellular immunoglobulin (Ig)-like domain, and a short cytoplasmic tail[1][5]. Its gene is located at chromosome 1q32.1 and encodes a 255-amino-acid protein, highly conserved among vertebrates[1][3]. TMEM81 is ubiquitously expressed in humans with enhanced levels in cerebellum, testis, and spleen, and is present in spermatids of both mice and humans[1][3]. Structural studies identify TMEM81 as a close homolog of sperm fusion molecules (IZUMO1, SPACA6), suggesting a putative role in gamete membrane fusion or recognition[2][3][7]. Clinically, methylation changes or genetic variation in TMEM81 are associated with several diseases, including breast cancer, Meniere’s disease, mean platelet volume traits, and intermittent explosive disorder[1]. No drugs are currently known to target TMEM81, and its function and clinical utility remain incompletely characterized.

Other names
TMEM81HC3107KVLA2788UNQ2788MGC75217transmembrane protein 81
02

Biological functions

Sperm-egg recognitionPossible role in gamete fusionStructural membrane protein
03

Disease associations

CancerMeniere’s diseaseThrombopoietic traits (mean platelet volume)Intermittent explosive disorderHepatocellular carcinoma
04

Biomarkers

Methylation status (potential biomarker in intermittent explosive disorder)Copy number gain (potential marker in some cancers)SNPs affecting thrombopoiesis (potential marker)

Beyond the preview

Go deeper on Transmembrane protein 81 (TMEM81).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 81 (TMEM81).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call